genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2016
Pediatrics
News
Sugar-Sweetened Beverages Warning Labels
News
New Human Genetic Brain Disorder Identified
Infectious Diseases
ViiV Licenses Adult, Pediatric DTG to Generic Drugmakers for Developing World
Cancer
Exploring Alcoholism Drug’s Potential Against Brain Tumors
News
FDA Clears Discovery Laboratories’ Drug for Respiratory Distress Syndrome in Infants
News
BGI and The Children’s Hospital of Philadelphia Set Up Genome Center to Target Pediatric Diseases
News
New England Research Institutes Scores $45M to Support the Pediatric Heart Network
News
Positive Results for Phase III Pediatric Trial with Eisai’s Zonegran Epilepsy Drug
News
Cellular Dynamics and MCW Win $6.25M to Develop iPSC-Derived Ventricular Cells for Study of LVH
News
Guilty by Admission: Forest Forfeits $300M for Selling Unapproved Drug
1
2
3
4
5
Page 3 of 5
Scroll Up
Scroll Up
